CLNN
Price
$4.10
Change
+$0.02 (+0.49%)
Updated
Jun 13 closing price
Capitalization
36.83M
FBRX
Price
$12.09
Change
-$0.45 (-3.59%)
Updated
Jun 13 closing price
Capitalization
79.56M
Interact to see
Advertisement

CLNN vs FBRX

Header iconCLNN vs FBRX Comparison
Open Charts CLNN vs FBRXBanner chart's image
Clene
Price$4.10
Change+$0.02 (+0.49%)
Volume$70.86K
Capitalization36.83M
Forte Biosciences
Price$12.09
Change-$0.45 (-3.59%)
Volume$34.41K
Capitalization79.56M
CLNN vs FBRX Comparison Chart
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. FBRX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a Hold and FBRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (CLNN: $4.10 vs. FBRX: $12.09)
Brand notoriety: CLNN and FBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 71% vs. FBRX: 86%
Market capitalization -- CLNN: $36.83M vs. FBRX: $79.56M
CLNN [@Biotechnology] is valued at $36.83M. FBRX’s [@Biotechnology] market capitalization is $79.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileFBRX’s FA Score has 0 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • FBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 5 TA indicator(s) are bullish while FBRX’s TA Score has 6 bullish TA indicator(s).

  • CLNN’s TA Score: 5 bullish, 5 bearish.
  • FBRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, FBRX is a better buy in the short-term than CLNN.

Price Growth

CLNN (@Biotechnology) experienced а -3.53% price change this week, while FBRX (@Biotechnology) price change was +6.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CLNN is expected to report earnings on Mar 24, 2025.

FBRX is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBRX($79.6M) has a higher market cap than CLNN($36.8M). CLNN YTD gains are higher at: -22.787 vs. FBRX (-46.786). CLNN has higher annual earnings (EBITDA): -24.01M vs. FBRX (-35.6M). FBRX has more cash in the bank: 16.4M vs. CLNN (9.83M). CLNN has higher revenues than FBRX: CLNN (350K) vs FBRX (0).
CLNNFBRXCLNN / FBRX
Capitalization36.8M79.6M46%
EBITDA-24.01M-35.6M67%
Gain YTD-22.787-46.78649%
P/E RatioN/AN/A-
Revenue350K0-
Total Cash9.83M16.4M60%
Total Debt20.9MN/A-
FUNDAMENTALS RATINGS
CLNN vs FBRX: Fundamental Ratings
CLNN
FBRX
OUTLOOK RATING
1..100
3649
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
4436
P/E GROWTH RATING
1..100
9550
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLNN's Valuation (86) in the null industry is in the same range as FBRX (98). This means that CLNN’s stock grew similarly to FBRX’s over the last 12 months.

CLNN's Profit vs Risk Rating (100) in the null industry is in the same range as FBRX (100). This means that CLNN’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's SMR Rating (96) in the null industry is in the same range as CLNN (99). This means that FBRX’s stock grew similarly to CLNN’s over the last 12 months.

FBRX's Price Growth Rating (36) in the null industry is in the same range as CLNN (44). This means that FBRX’s stock grew similarly to CLNN’s over the last 12 months.

FBRX's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for CLNN (95). This means that FBRX’s stock grew somewhat faster than CLNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLNNFBRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XOM112.122.39
+2.18%
Exxon Mobil Corp
DKL43.500.17
+0.39%
Delek Logistics Partners LP
SOTK3.69-0.08
-2.12%
Sono-Tek Corp
LEVI16.72-0.38
-2.22%
Levi Strauss & Co
HONE11.22-0.30
-2.60%
HarborOne Bancorp

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with LYRA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
+0.49%
LYRA - CLNN
38%
Loosely correlated
-4.30%
VERA - CLNN
34%
Loosely correlated
+0.98%
KZIA - CLNN
33%
Poorly correlated
-5.01%
BPMC - CLNN
31%
Poorly correlated
-0.19%
GOSS - CLNN
30%
Poorly correlated
-2.36%
More

FBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBRX has been loosely correlated with QSI. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if FBRX jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
-3.63%
QSI - FBRX
33%
Loosely correlated
-7.26%
AXON - FBRX
31%
Poorly correlated
+0.70%
ARRY - FBRX
28%
Poorly correlated
+7.13%
CLNN - FBRX
27%
Poorly correlated
+0.49%
CDTX - FBRX
27%
Poorly correlated
-5.85%
More